2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
Umeclidinium bromide(GSK573719A) is a muscarinic receptor antagonist which is useful in treatment of chronic obstructive pulmonary disease (COPD). For the detailed information of Umeclidinium bromide(GSK573719A), the solubility of Umeclidinium bromide(GSK573719A) in water, the solubility of Umeclidinium bromide(GSK573719A) in DMSO, the solubility of Umeclidinium bromide(GSK573719A) in PBS buffer, the animal experiment (test) of Umeclidinium bromide(GSK573719A), the cell expriment (test) of Umeclidinium bromide(GSK573719A), the in vivo, in vitro and clinical trial test of Umeclidinium bromide(GSK573719A), the EC50, IC50,and affinity,of Umeclidinium bromide(GSK573719A), For the detailed information of Umeclidinium bromide(GSK573719A), the solubility of Umeclidinium bromide(GSK573719A) in water, the solubility of Umeclidinium bromide(GSK573719A) in DMSO, the solubility of Umeclidinium bromide(GSK573719A) in PBS buffer, the animal experiment (test) of Umeclidinium bromide(GSK573719A), the cell expriment (test) of Umeclidinium bromide(GSK573719A), the in vivo, in vitro and clinical trial test of Umeclidinium bromide(GSK573719A), the EC50, IC50,and affinity,of Umeclidinium bromide(GSK573719A), Please contact DC Chemicals.
